Specialty Drugs, GLP-1s, and the New Employer Pharmacy Reality

In this episode of Benefits Breakdown, the team is joined by Josh Halperin, Senior Vice President of Pharmacy Consulting Services at Brown & Brown. Together, they explore the rapidly changing pharmacy landscape—how the surge in specialty drug approvals, the rise of GLP-1 medications, and shifting oncology treatments are reshaping employer health plans. The conversation unpacks the financial impact of these trends, the promise of biosimilars, and the challenges posed by new legislation, direct-to-consumer pharmacy models, and drug import tariffs.  Whether you’re a benefits leader, HR professional, or simply passionate about the future of pharmacy benefits, this episode delivers actionable insights and real-world strategies to help you navigate complexity, control costs, and plan for what’s next. Connect with the hosts: Jared Bowcutt Vanessa Longnecker Adam Compton